Northwest Biotherapeutics, Inc. operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Northwest Biotherapeutics with three other
companies in this sector in the United States:
sales of $2.18 million
of which 100%
Ocular Therapeutix Inc
Enumeral Biomedical Holdings Inc
During the year ended December of 2015, sales at
Northwest Biotherapeutics were $1.74 million.
increase of 19.6%
versus 2014, when the company's sales were $1.45 million.
This was the fourth straight year of sales growth at Northwest Biotherapeutics.